保诺－桑迪亚旗下两家研发生产基地获得ISO 27001认证 | Bilingual

中国上海，2024年9月10日 ―― 保诺－桑迪亚宣布其在中国的两个研发生产基地（上海外高桥和无锡）已正式获得ISO 27001认证，达到了全球信息安全管理的高标准要求。

ISO 27001标准是信息安全管理系统的国际标准，为组织建立、实施和维护信息安全管理系统（ISMS）提供了指导。该认证彰显了公司强大的数据保护能力和对信息安全的坚定承诺，确保能为我们全球合作伙伴的知识产权提供高级别的保护。

公司在美国和中国的7个研发生产基地使用统一的数据和信息管理体系。继上海外高桥和无锡之后，公司计划在 2025 年对更多生产研发基地进行ISO 27001认证评估。

公司执行委员会主席 Gary Chu先生表示：“我们非常荣幸获得ISO 27001认证。这一成就不仅反映了我们在信息安全管理领域的卓越努力，也体现了我们为客户和合作伙伴提供数据保护的承诺。我们将继续致力于提升信息安全水平，以应对不断变化的数据安全挑战。”

关于保诺-桑迪亚

保诺－桑迪亚，安宏资本旗下投资企业之一，成立于1996年，是一家全球化的合同研究、开发和生产公司（CRDMO）。公司总部位于加州尔湾，在美国和中国设有7个研发生产中心，全球员工总数超过 2000人。我们为生物技术和制药企业提供从早期靶点确证到商业化生产的整合服务，尤其擅长大小分子发现、开发、放大和生产服务。保诺-桑迪亚独特的技术平台和整合服务可加速新药研发进程、降低开发风险，从而创造更高的价值。我们遵循全球高标准的合规和运营准则，科学驱动、以客户为导向、多元化和以人为本的企业文化。保诺-桑迪亚专注于纯粹的CRDMO服务，在全球化质量标准体系下运营，提供先进、快速和灵活的服务，以满足生物技术和制药企业的专属需求，加快新药开发进程。

更多信息，请访问公司官网https://www.bioduro-sundia.cn

Irvine, CA, USA, September 10, 2024 – BioDuro-Sundia announced its two sites, Shanghai Waigaoqiao site and Jiangsu site in China, has officially received ISO 27001 certification, meeting the high global standard for information security management. 

ISO 27001 is an international standard for information security management that provides guidelines for organizations to establish, implement, and manage an information security management system (ISMS).  The certification underscores the company’s robust capabilities and unwavering commitment to safeguarding data and information security, ensuring the highest level of protection for the intellectual property of our global partners.

The company’s 7 sites across the US and China share the system for data and information management.  After Shanghai Waigaoqiao and Jiangsu sites, more sites are slated to take evaluations for ISO 27001 certification in 2025. 

Mr. Gary Chu, Chairman of the Executive Committee of the company, stated, “I am excited that our two sites in China received the ISO 27001 certification. This achievement reflects not only our excellence in the field of information security management but also our commitment to data protection for our customers and partners. We will continue to enhance our information security capabilities, addressing the ever-changing data security challenges.” 

About BioDuro-Sundia

BioDuro-Sundia, an Advent International portfolio company, is a global contract research, development, and manufacturing organization (CRDMO) founded in 1996. Global headquartered in Irvine, California, our global presence spans 7 sites across the US and China, totaling 2,000+ employees. Specializing in small and large molecule discovery, development, scale-up and manufacturing, we offer fully integrated services from target identification to commercial drug product manufacturing.  At BioDuro-Sundia, we leverage our unique technology platforms to support biotech and pharmaceutical partners worldwide. Our comprehensive approach accelerates discovery, de-risks development, and creates higher value outcomes for our clients. Committed to the highest standards of compliance and business operations, we maintain a science-driven, customer-oriented, diversified and people-focused culture.  Dedicated to CRDMO services, BioDuro-Sundia operates under one global standard, providing integrated, fast, and flexible services to meet the unique needs of our clients and accelerate development timelines.

For more information, please visit https://www.bioduro-sundia.com